Esmolol may abolish volatile anesthetic-induced postconditioning by scavenging reactive oxygen species.
Xia
Zhengyuan
Z
Irwin
Michael G
MG
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D018685:Anesthetics, Inhalation / Q000494:pharmacology*; D000818:Animals; D002316:Cardiotonic Agents; D016166:Free Radical Scavengers; D009203:Myocardial Infarction / Q000473:pathology / Q000517:prevention & control; D011412:Propanolamines / Q000627:therapeutic use*; D011817:Rabbits; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015427:Reperfusion Injury / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D018685:Anesthetics, Inhalation; D002316:Cardiotonic Agents; D016166:Free Radical Scavengers; D011412:Propanolamines; D017382:Reactive Oxygen Species; C036604:esmolol